HIV molecular immunology database
Found 7 matching records:
HXB2 Location | Gag(147-155) | Gag Epitope Map
View variants at this location |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
ISPRTLNAW
|
Epitope Alignment | ||||||||||||||||
Variants |
|
|||||||||||||||||
Epitope Name | ISW9 | |||||||||||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 5 variant(s).
Variant ID. | 3339 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | lSPRTLNAW |
Mutations | I/L |
Epitope Location | I1L |
HXB2 Location | I147L |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant lSPRTLNAW, was seen in 2/3 HRPs and 2/3 LRPs. lSPRTLNAW was the only analogous ISW9 in patient P1 and was found in the major viral population in patients P5 and P6 at latter time points. |
Variant ID. | 3340 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | ltPRTLNAW |
Mutations | I/L S/T |
Epitope Location | I1L S2T |
HXB2 Location | I147L S148T |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant ltPRTLNAW, was seen in 0/3 HRPs and 1/3 LRPs (patient P4) at the last sampling point. |
Variant ID. | 3341 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | ItPRTLNAW |
Mutations | S/T |
Epitope Location | S2T |
HXB2 Location | S148T |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant ItPRTLNAW, was seen in 0/3 HRPs and 1/3 LRPs. It was the predominant variant in subject P4. |
Variant ID. | 3342 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | IaPRTLNAW |
Mutations | S/A |
Epitope Location | S2A |
HXB2 Location | S148A |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant ItPRTLNAW, was seen in 1/3 HRPs and 0/3 LRPs. It was the predominant variant in subject P4. |
Variant ID. | 3343 |
---|---|
Epitope Seq. | ISPRTLNAW |
Variant Seq. | IlPRTLNAW |
Mutations | S/L |
Epitope Location | S2L |
HXB2 Location | S148L |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant IlPRTLNAW, was seen in 1/3 HRPs and 0/3 LRPs. It was an early variant in Gag that was later lost in subject P3. |
Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.
HXB2 Location | Gag(162-172) | Gag Epitope Map
View variants at this location |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
KAFSPEVIPMF
|
Epitope Alignment | |||||||||||||
Variants |
|
||||||||||||||
Epitope Name | KF11 | ||||||||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 4 variant(s).
Variant ID. | 3344 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KAFSPEVIPMs |
Mutations | F/S |
Epitope Location | F11S |
HXB2 Location | F172S |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KAFSPEVIPMs was seen in 1/3 HRP subjects (patient P1). |
Variant ID. | 3345 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KAFSPEVIPMt |
Mutations | F/T |
Epitope Location | F11T |
HXB2 Location | F172T |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KAFSPEVIPMt was seen in 1/3 HRP (patient P1) and 1/3 LRP (patient P6) subjects. |
Variant ID. | 3346 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KAFSPEiIPMF |
Mutations | V/I |
Epitope Location | V7I |
HXB2 Location | V168I |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KAFSPEiIPMF was seen in 1/3 HRP (patient P1) and 1/3 LRP (patient P6) subjects. |
Variant ID. | 3347 |
---|---|
Epitope Seq. | KAFSPEVIPMF |
Variant Seq. | KAsSPEVIPMF |
Mutations | F/S |
Epitope Location | F3S |
HXB2 Location | F164S |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KAsSPEVIPMF was seen in 1/3 LRP (patient P6) subjects. |
Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.
HXB2 Location | Gag(240-249) | Gag Epitope Map
View variants at this location |
|||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
TSTLQEQIGW
|
Epitope Alignment | |||||||||||||||||||||||||
Variants |
|
||||||||||||||||||||||||||
Epitope Name | TW10 | ||||||||||||||||||||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 8 variant(s).
Variant ID. | 3348 |
---|---|
Epitope Seq. | TSTLQEQIGW |
Variant Seq. | TSTLrEQIGW |
Mutations | Q/R |
Epitope Location | Q5R |
HXB2 Location | Q244R |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant TSTLrEQIGW was seen in 1/3 HRP (patient P1) subjects. |
Variant ID. | 3349 |
---|---|
Epitope Seq. | TSTLQEQIGW |
Variant Seq. | TSTLQEQIeW |
Mutations | Q/R G/E |
Epitope Location | Q5R G9E |
HXB2 Location | Q244R G248E |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant TSTLQEQIeW was seen in 1/3 HRP (patient P1) and 1/3 LRP (patient 5) subjects. |
Variant ID. | 3350 |
---|---|
Epitope Seq. | TSTLQEQIGW |
Variant Seq. | TSsLQEQIGW |
Mutations | T/S |
Epitope Location | T3S |
HXB2 Location | T242S |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant TSTLrEQIeW was seen in 1/3 HRP (patient P2) subjects. |
Variant ID. | 3351 |
---|---|
Epitope Seq. | TSTLQEQIGW |
Variant Seq. | TSnLQEQIGW |
Mutations | T/N |
Epitope Location | T3N |
HXB2 Location | T242N |
Mutation Type | E: escape documented in this paper OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant TSnLQEQIGW, TW10-3N was seen in all 6 HRP and LRP subjects. |
Variant ID. | 3352 |
---|---|
Epitope Seq. | TSTLQEQIGW |
Variant Seq. | TSnLQEQIrW |
Mutations | T/N G/R |
Epitope Location | T3N G9R |
HXB2 Location | T242N G248R |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant TSnLQEQIrW was seen in all 1/3 HRP (patient P2) subjects. |
Variant ID. | 3353 |
---|---|
Epitope Seq. | TSTLQEQIGW |
Variant Seq. | TSnLQEQItW |
Mutations | T/N G/T |
Epitope Location | T3N G9T |
HXB2 Location | T242N G248T |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant TSnLQEQItW was seen in all 1/3 HRP (patient P2) subjects. |
Variant ID. | 3354 |
---|---|
Epitope Seq. | TSTLQEQIGW |
Variant Seq. | TSnLQEQIaW |
Mutations | T/N G/A |
Epitope Location | T3N G9A |
HXB2 Location | T242N G248A |
Mutation Type | E: escape documented in this paper OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant TSnLQEQIaW, TW10-3N-9A, was seen in 1/3 HRP (patient P3) and 1/3 LRP (patient 5) subjects. It was the analogous epitope of the major viral population at the last time point in patient P1, the earliest time point in patients P2 and P3, and the only variant in LRP patients P4 and P6. |
Variant ID. | 3355 |
---|---|
Epitope Seq. | TSTLQEQIGW |
Variant Seq. | TSTLQEQIaW |
Mutations | G/A |
Epitope Location | G9A |
HXB2 Location | G248A |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant TSTLQEQIaW was seen in 1/3 LRP (patient 5) subjects. |
Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.
HXB2 Location | Gag(308-316) | Gag Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
QASQEVKNW
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | QW9 | ||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 2 variant(s).
Variant ID. | 3356 |
---|---|
Epitope Seq. | QASQEVKNW |
Variant Seq. | QASQdVKNW |
Mutations | E/D |
Epitope Location | E5D |
HXB2 Location | E312D |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant QASQdVKNW was seen in 2/3 HRP and no LRP subjects. It was the analogous epitope of the major viral population at the last time points in patient P3, the earliest time point in patient P1. |
Variant ID. | 3357 |
---|---|
Epitope Seq. | QASQEVKNW |
Variant Seq. | QASQtVKNW |
Mutations | E/T |
Epitope Location | E5T |
HXB2 Location | E312T |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant QASQtVKNW was seen in 1/3 HRP and no LRP subjects. It was the only analogous epitope of the major viral population patient P2. |
Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.
HXB2 Location | Nef(82-91) | Nef Epitope Map
View variants at this location |
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
KAALDLSHFL
|
Epitope Alignment | |||||||||||||||||||
Variants |
|
||||||||||||||||||||
Epitope Name | KL10 | ||||||||||||||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 6 variant(s).
Variant ID. | 3358 |
---|---|
Epitope Seq. | KAALDLSHFL |
Variant Seq. | KAALDLSHlL |
Mutations | F/L |
Epitope Location | F9L |
HXB2 Location | F90L |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KAALDLSHlL was seen in 1/3 HRP (patient P2) and 2/3 LRP (patients P4, P6) subjects. |
Variant ID. | 3359 |
---|---|
Epitope Seq. | KAALDLSHFL |
Variant Seq. | rAALDLSHFL |
Mutations | K/R |
Epitope Location | K1R |
HXB2 Location | K82R |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant rAALDLSHlL was seen in 1/3 LRP (patient P6) and no HRP subjects. |
Variant ID. | 3360 |
---|---|
Epitope Seq. | KAALDLSHFL |
Variant Seq. | rAALDLSHlL |
Mutations | K/R F/L |
Epitope Location | K1R F9L |
HXB2 Location | K82R F90L |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant rAALDLSHlL was seen in no HRP and 1/3 LRP (patient P6) subjects. |
Variant ID. | 3361 |
---|---|
Epitope Seq. | KAALDLSHFL |
Variant Seq. | rAAvDLSHFL |
Mutations | K/R L/V |
Epitope Location | K1R L4V |
HXB2 Location | K82R L85V |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant rAAvDLSHFL was seen in no HRP and 1/3 LRP (patient P6) subjects and was the major analogous epitope at later time points. |
Variant ID. | 3362 |
---|---|
Epitope Seq. | KAALDLSHFL |
Variant Seq. | KgALDLSHFL |
Mutations | A/G |
Epitope Location | A2G |
HXB2 Location | A83G |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KgALDLSHFL was seen in 1/3 HRP (patient P3) and 1/3 (patient P4) LRP subjects. It was the autologous epitope of the major viral population in the later time points for the LRP but the only epitope in the HRP. |
Variant ID. | 3363 |
---|---|
Epitope Seq. | KAALDLSHFL |
Variant Seq. | KAAvDLSHFL |
Mutations | L/V |
Epitope Location | L4V |
HXB2 Location | L85V |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant KAAvDLSHFL was seen in no HRP and 2/3 LRP subjects. It was the autologous epitope of the major viral population at the first time point for the patient P6 but was then lost. |
Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.
HXB2 Location | Nef(116-125) | Nef Epitope Map
View variants at this location |
||||
---|---|---|---|---|---|---|
Epitope |
HTQGYFPDWQ
|
Epitope Alignment | ||||
Variants |
|
|||||
Epitope Name | HQ10 | |||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 1 variant(s).
Variant ID. | 3364 |
---|---|
Epitope Seq. | HTQGYFPDWQ |
Variant Seq. | nTQGYFPDWQ |
Mutations | H/N |
Epitope Location | H1N |
HXB2 Location | H116N |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant nTQGYFPDWQ was seen in 2/3 HRP and all 3 LRP subjects. It was the autologous epitope of the major viral population in patients P2, P3 and P6; and it was the only form in patients P4 and P5. |
Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.
HXB2 Location | Nef(120-128) | Nef Epitope Map
View variants at this location |
|||||||
---|---|---|---|---|---|---|---|---|---|
Epitope |
YFPDWQNYT
|
Epitope Alignment | |||||||
Variants |
|
||||||||
Epitope Name | YT9 | ||||||||
Species (MHC/HLA) | human(B*57:01) |
Showing all: 2 variant(s).
Variant ID. | 3365 |
---|---|
Epitope Seq. | YFPDWQNYT |
Variant Seq. | YFPDWQcYT |
Mutations | N/C |
Epitope Location | N7C |
HXB2 Location | N126C |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant YFPDWQcYT was an autologous epitope found in 1/3 HRP (patient P2) and 1/3 LRP (patient P4). |
Variant ID. | 3366 |
---|---|
Epitope Seq. | YFPDWQNYT |
Variant Seq. | YFPDWQchT |
Mutations | N/C Y/H |
Epitope Location | N7C Y8H |
HXB2 Location | N126C Y127H |
Mutation Type | OV: observed variant |
Epitope Subtype | B |
Variant Subtype | B |
Method | HLA binding, Intracellular cytokine staining, Sequence |
Note | Variant YFPDWQchT was an autologous epitope found in no HRP and 1/3 LRP (patient P4). |
Buggert2014 Marcus Buggert, Melissa M. Norström, Marco Salemi, Frederick M. Hecht, and Annika C. Karlsson. Functional Avidity and IL-2/Perforin Production Is Linked to the Emergence of Mutations within HLA-B*5701-Restricted Epitopes and HIV-1 Disease Progression. J. Immunol., 192(10):4685-4696, 15 May 2014. PubMed ID: 24740510. Show all entries for this paper.